IPO registrations (S-1, F-1) · Registrants
Abcam plc
- SEC CIK
- 1492074 · filings on EDGAR ↗
- Registration
- Form F-1, first filed 2020-10-02, last 2020-10-21; 1 initial registration, 3 amendments
- Outcome
- Final prospectus filed 2020-10-22; declared effective 2020-10-21
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- X0
- Business address
- DISCOVERY DRIVE, CAMBRIDGE BIOMEDICAL CAMPUS, Cambridge, X0 CB2 0AX
- EIN
- 98-0487031
- EDGAR entity type
- other
Offering terms
- Final price
- $17.50 per ADS (424B4 filed 2020-10-22, an initial public offering)
- Shares sold
- 8,945,218
- Gross proceeds
- $156,541,315 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ABCM
- Lead underwriters
- Morgan Stanley; BofA Securities
- Syndicate
- Leerink Partners; Lazard; William Blair; FINRA filing fee (25,991); Stock Exchange listing fee (150,000); AIM listing fee (47,648); Miscellaneous costs (100,963)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: Abcam plc EXACT (CIK (EXACT))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-10-02 | F-1 | F-1 (foreign registration) | Abcam plc | 0001193125-20-262444 ↗ |
| 2020-10-19 | F-1/A | F-1/A (amendment) | Abcam plc | 0001193125-20-271612 ↗ |
| 2020-10-21 | F-1/A | F-1/A (amendment) | Abcam plc | 0001193125-20-273300 ↗ |
| 2020-10-21 | F-1/A | F-1/A (amendment) | Abcam plc | 0001193125-20-273683 ↗ |
| 2020-10-21 | F-1MEF | F-1MEF (added securities) | Abcam plc | 0001193125-20-273841 ↗ |
| 2020-10-21 | EFFECT | EFFECT (declared effective) | Abcam plc | 9999999995-20-002933 ↗ |
| 2020-10-22 | 424B4 | 424B4 (final prospectus) | Abcam plc | 0001193125-20-274479 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-10-21 | F-1/A | registration statement | 49,416 | - | 0 | primary document; shares headline | document ↗ | |||
| 2020-10-22 | 424B4 | final prospectus | $17.50 | 8,945,218 | $156,541,315 | Nasdaq ABCM | 9 | primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 5 | document ↗ |
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2020-03-12 | Abcam plc | Other Health Care | $800,000 | $800,000 | 3 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Abcam plc | Form D private offerings | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), X0 first:
- Immunocore Holdings plc X0
- Autolus Therapeutics plc X0
- Orchard Therapeutics plc X0
- Freeline Therapeutics Holdings plc X0
- Achilles Therapeutics plc X0
- Gyroscope Therapeutics Holdings plc X0
- OKYO Pharma Ltd X0
- Exscientia plc X0
- TC BioPharm (Holdings) plc X0
- BioNTech SE 2M
In other datasets, the same topic (Health) in X0:
- Form D issuer: Abcam plc (Form D private offerings)
Interests: Biological Products, (No Diagnostic Substances) · Health